TLDR Citi cut DocuSign from Buy to Neutral, slashing its price target from $99 to $50 DOCU fell roughly 6% on the day, extending a two-day losing streak FiscalTLDR Citi cut DocuSign from Buy to Neutral, slashing its price target from $99 to $50 DOCU fell roughly 6% on the day, extending a two-day losing streak Fiscal

DocuSign (DOCU) Stock Had a Very Bad Week — Here’s Why

2026/04/11 19:59
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Citi cut DocuSign from Buy to Neutral, slashing its price target from $99 to $50
  • DOCU fell roughly 6% on the day, extending a two-day losing streak
  • Fiscal 2026 revenue grew just 8%, making the prior valuation hard to defend
  • Fears around AI-native rivals disrupting the SaaS model added to selling pressure
  • DOCU is now down ~34.5% year-to-date, trading 54.7% below its 52-week high

DocuSign has had a rough couple of days. The electronic signature company saw its stock drop around 6% on April 10 after Citigroup downgraded it from Buy to Neutral, cutting its price target from $99 to $50. That is a steep haircut, and the market took notice quickly.


DOCU Stock Card
DocuSign, Inc., DOCU

The downgrade came down to one core issue: growth. DocuSign posted fiscal 2026 revenue growth of just 8%. For a company that once commanded a premium valuation, single-digit growth is a tough sell to investors expecting more.

Citi’s analyst flagged that the slower pace makes it hard to justify where the stock was previously priced. The new $50 target reflects a more cautious view of what DocuSign can realistically deliver from here.

The Citi downgrade didn’t happen in a vacuum. The day before, DOCU had already slipped 4.4% as broader market anxiety picked up.

Part of that earlier drop tied back to geopolitical tension — reports of a ceasefire breach in the Middle East rattled markets and pushed investors toward the exits on higher-risk names.

But another trigger was closer to home for tech investors. Anthropic’s launch of Managed Agents — autonomous AI systems designed to handle complex, multi-step tasks — stirred concern that traditional SaaS tools could face real pressure from AI-native platforms.

AI Competition Weighs on Sentiment

The worry isn’t abstract. If AI agents can perform tasks that previously required dedicated software like DocuSign, the addressable market for those tools could shrink over time.

Short seller Michael Burry added fuel to the fire with a since-deleted social media post suggesting Anthropic was “eating Palantir’s lunch.” The comment was quickly removed, but not before traders noticed — and not before it added to the general unease around legacy SaaS platforms.

It’s worth noting DOCU has now had 16 single-day moves of more than 5% over the past year. The stock is clearly sensitive to news, and investors are quick to reprice it.

Where the Stock Stands Now

At $42.49 per share, DocuSign is trading 54.7% below its 52-week high of $93.84, which it hit back in June 2025.

Year-to-date, the stock is down around 34.5%. That’s a steep decline in just over three months.

To put it in perspective: someone who put $1,000 into DocuSign five years ago would be sitting on roughly $199 today.

The technical picture isn’t encouraging either. Trading volume has averaged over 5 million per day, and the technical sentiment signal is currently reading as Sell.

The market cap now sits at approximately $8.86 billion, down substantially from where it stood when growth expectations were higher.

Citi’s $50 price target is now the most recent analyst revision on record for the stock.

The post DocuSign (DOCU) Stock Had a Very Bad Week — Here’s Why appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!